Lipidoses
Showing 1 - 23 of 23
Cholesterol; Lipidosis Trial in Kansas City (Rosuvastatin 10mg)
Recruiting
- Cholesterol; Lipidosis
- Rosuvastatin 10mg
-
Kansas City, MissouriChildren's Mercy Hospital
Jul 1, 2022
Sphingomyelin Lipidosis Trial (olipudase alfa (GZ402665))
Approved for marketing
- Sphingomyelin Lipidosis
- olipudase alfa (GZ402665)
- (no location specified)
Sep 15, 2022
Lipid Storage Disease Trial in Istanbul
Not yet recruiting
- Lipid Storage Disease
-
Istanbul, TurkeyIstanbul University
Mar 29, 2022
Hypertension, Diet, Healthy, Body Weight Trial in Elche (CONTROL GROUP, HEALTH APP GROUP)
Active, not recruiting
- Hypertension
- +5 more
- CONTROL GROUP
- HEALTH APP GROUP
-
Elche, Alicante, SpainNutriciĆ³n Selecta
Nov 18, 2021
Cholesterol; Lipidosis Trial in Subang Jaya (Mindfulness practice)
Recruiting
- Cholesterol; Lipidosis
- Mindfulness practice
-
Subang Jaya, Selangor, MalaysiaMonash University Malaysia
Apr 6, 2021
Sphingomyelin Lipidosis Trial in Worldwide (Olipudase alfa)
Completed
- Sphingomyelin Lipidosis
- Olipudase alfa
-
New York, New York
- +5 more
Mar 15, 2022
IBD, Crohn Disease, Polyunsaturated Acid Lipidosis Trial (azathioprine, infliximab, N-3 Polyunsaturated Fatty Acids)
Not yet recruiting
- Inflammatory Bowel Diseases
- +2 more
- azathioprine
- +2 more
- (no location specified)
Feb 18, 2021
Krabbe Disease Trial in Ann Arbor (FBX-101)
Recruiting
- Krabbe Disease
- FBX-101
-
Ann Arbor, MichiganUniversity of Michigan Hospitals - Michigan Medicine
Feb 13, 2023
Metabolism, Inborn Errors, Lipid Metabolism, Inborn Errors, Carbohydrate Metabolism, Inborn Errors Trial in Copenhagen (Sugar)
Unknown status
- Metabolism, Inborn Errors
- +22 more
- Sugar
-
Copenhagen, DenmarkNeuromuscular Research Unit, 3342
Oct 15, 2019
Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV), Neutral Lipid Storage Disease With Myopathy (NLSD-M) Trial in Italy,
Terminated
- Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV)
- Neutral Lipid Storage Disease With Myopathy (NLSD-M)
- CNT-02
-
Rome, Lazio, Italy
- +6 more
Jul 4, 2019
Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease
Completed
- Lysosomal Storage Diseases
- +2 more
-
Tirana, Albania
- +7 more
May 27, 2021
Biomarker for Niemann Pick Type C Disease (BioNPC)
Active, not recruiting
- Niemann-Pick Disease
- Niemann-Pick Disease, Type C
-
Rostock, Germany
- +3 more
May 12, 2021
DASH Dietary Pattern and Cardiometabolic Risk
Unknown status
- Cardiovascular Risk Factor
- +8 more
- DASH dietary pattern
-
Toronto, Ontario, CanadaThe Toronto 3D (Diet, Digestive tract and Disease) Knowledge Syn
Dec 5, 2018
Meta-analysis of Portfolio Dietary Pattern and Cardiometabolic
Unknown status
- Cardiovascular Risk Factor
- Cholesterol; Lipidosis
- Portfolio Dietary Pattern
- NCEP Based Diet
-
Toronto, Ontario, CanadaThe Toronto 3D (Diet, Digestive tract and Disease) Knowledge Syn
May 21, 2018
Farber Disease Natural History Study
Completed
- Farber Disease
- +6 more
-
Oakland, California
- +14 more
Jan 14, 2020
Lysosomal Acid Lipase Deficiency Trial in Worldwide (Sebelipase Alfa)
Completed
- Lysosomal Acid Lipase Deficiency
- Sebelipase Alfa
-
Chicago, Illinois
- +18 more
Nov 20, 2019
Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease Trial in Worldwide (Eliglustat
Completed
- Gaucher Disease, Type 1
- +4 more
- Eliglustat tartrate
-
New York, New York
- +16 more
Dec 22, 2016
Mixed Hyperlipoproteinemia Trial (Pro-Omega LDL, Placebo)
Withdrawn
- Mixed Hyperlipoproteinemia
- Pro-Omega LDL
- Placebo
- (no location specified)
Dec 10, 2015
Gaucher Disease Type I, Cerebroside Lipidosis Syndrome, Clucocerebrosidase Deficiency Disease Trial in Coral Springs (Cerezyme
Completed
- Gaucher Disease Type I
- +4 more
- Cerezyme (imiglucerase for injection)
-
Coral Springs, Florida(unnamed)
Mar 4, 2015
Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease Trial in Worldwide (Cerezyme)
Completed
- Gaucher Disease, Type 1
- +4 more
-
Washington, District of Columbia
- +25 more
Mar 17, 2015
Mixed Hyperlipidemia Trial in Seoul (Atorvastatin 10mg, fenofibric acid 135mg, atorvastatin 20mg)
Unknown status
- Mixed Hyperlipidemia
- Atorvastatin 10mg, fenofibric acid 135mg
- atorvastatin 20mg
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University College of Medicine
Oct 31, 2013
Neutral Lipid Storage Disease Trial in Maastricht (Fibrate treatment)
Completed
- Neutral Lipid Storage Disease
- Fibrate treatment
-
Maastricht, Limburg, NetherlandsMaastricht University Medical Center
May 13, 2013
Mixed Hyperlipidemia Trial in Worldwide (torcetrapib/atorvastatin, atorvastatin)
Terminated
- Mixed Hyperlipidemia
-
Gilbert, Arizona
- +50 more
Feb 15, 2012